世界のアンチトロンビンIIIテスト市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Anti-thrombin III Testing Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-3841 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、アンチトロンビンIIIテストの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（アンチトロンビン欠乏症診断、活性アッセイ、免疫学アッセイ）、用途別市場規模（病院、研究機関、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・アンチトロンビンIIIテストの市場動向 ・企業の競争状況、市場シェア ・アンチトロンビンIIIテストの種類別市場規模と予測2016-2027（アンチトロンビン欠乏症診断、活性アッセイ、免疫学アッセイ） ・アンチトロンビンIIIテストの用途別市場規模と予測2016-2027（病院、研究機関、診療所、その他） ・アンチトロンビンIIIテストの北米市場規模2016-2027（アメリカ、カナダ） ・アンチトロンビンIIIテストの欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・アンチトロンビンIIIテストのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・アンチトロンビンIIIテストの中南米市場規模2016-2027（メキシコ、ブラジル） ・アンチトロンビンIIIテストの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott Laboratories、Danaher Corp.、F. Hoffmann-La Roche Ltd.、Siemens Healthcare GmbH、Thermo Fisher Scientific Inc.） ・結論

Antithrombin (AT, Antithrombin III, ATIII) is a small glycoprotein produced by the liver that inactivates several enzymes of the coagulation system.
α-Antithrombin is the dominant form of antithrombin found in blood plasma and has an oligosaccharide occupying each of its four glycosylation sites. A single glycosylation site remains consistently un-occupied in the minor form of antithrombin, β-antithrombin.
Antithrombin activity is increased by anticoagulant heparin, which enhances the binding of antithrombin to factor II and factor X.
Antithrombin is a serpin (serine protease inhibitor) similar in structure to other plasma protease inhibitors like alpha 1-antichymotrypsin, alpha 2-antiplasmin and Heparin cofactor II.

Market Analysis and Insights: Global Anti-thrombin III Testing Market
The global Anti-thrombin III Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Anti-thrombin III Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Anti-thrombin III Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Anti-thrombin III Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Anti-thrombin III Testing market.

Global Anti-thrombin III Testing Scope and Market Size
Anti-thrombin III Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anti-thrombin III Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Diagnosis of antithrombin deficiency
Activity assays
Immunological assays

Segment by Application
Hospital
Research institute
Clinic
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott Laboratories
Danaher Corp.
F. Hoffmann-La Roche Ltd.
Siemens Healthcare GmbH
Thermo Fisher Scientific Inc.

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-thrombin III Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Diagnosis of antithrombin deficiency
1.2.3 Activity assays
1.2.4 Immunological assays
1.3 Market by Application
1.3.1 Global Anti-thrombin III Testing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Research institute
1.3.4 Clinic
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Anti-thrombin III Testing Market Perspective (2016-2027)
2.2 Anti-thrombin III Testing Growth Trends by Regions
2.2.1 Anti-thrombin III Testing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Anti-thrombin III Testing Historic Market Share by Regions (2016-2021)
2.2.3 Anti-thrombin III Testing Forecasted Market Size by Regions (2022-2027)
2.3 Anti-thrombin III Testing Industry Dynamic
2.3.1 Anti-thrombin III Testing Market Trends
2.3.2 Anti-thrombin III Testing Market Drivers
2.3.3 Anti-thrombin III Testing Market Challenges
2.3.4 Anti-thrombin III Testing Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Anti-thrombin III Testing Players by Revenue
3.1.1 Global Top Anti-thrombin III Testing Players by Revenue (2016-2021)
3.1.2 Global Anti-thrombin III Testing Revenue Market Share by Players (2016-2021)
3.2 Global Anti-thrombin III Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Anti-thrombin III Testing Revenue
3.4 Global Anti-thrombin III Testing Market Concentration Ratio
3.4.1 Global Anti-thrombin III Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-thrombin III Testing Revenue in 2020
3.5 Anti-thrombin III Testing Key Players Head office and Area Served
3.6 Key Players Anti-thrombin III Testing Product Solution and Service
3.7 Date of Enter into Anti-thrombin III Testing Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Anti-thrombin III Testing Breakdown Data by Type
4.1 Global Anti-thrombin III Testing Historic Market Size by Type (2016-2021)
4.2 Global Anti-thrombin III Testing Forecasted Market Size by Type (2022-2027)

5 Anti-thrombin III Testing Breakdown Data by Application
5.1 Global Anti-thrombin III Testing Historic Market Size by Application (2016-2021)
5.2 Global Anti-thrombin III Testing Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Anti-thrombin III Testing Market Size (2016-2027)
6.2 North America Anti-thrombin III Testing Market Size by Type
6.2.1 North America Anti-thrombin III Testing Market Size by Type (2016-2021)
6.2.2 North America Anti-thrombin III Testing Market Size by Type (2022-2027)
6.2.3 North America Anti-thrombin III Testing Market Size by Type (2016-2027)
6.3 North America Anti-thrombin III Testing Market Size by Application
6.3.1 North America Anti-thrombin III Testing Market Size by Application (2016-2021)
6.3.2 North America Anti-thrombin III Testing Market Size by Application (2022-2027)
6.3.3 North America Anti-thrombin III Testing Market Size by Application (2016-2027)
6.4 North America Anti-thrombin III Testing Market Size by Country
6.4.1 North America Anti-thrombin III Testing Market Size by Country (2016-2021)
6.4.2 North America Anti-thrombin III Testing Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Anti-thrombin III Testing Market Size (2016-2027)
7.2 Europe Anti-thrombin III Testing Market Size by Type
7.2.1 Europe Anti-thrombin III Testing Market Size by Type (2016-2021)
7.2.2 Europe Anti-thrombin III Testing Market Size by Type (2022-2027)
7.2.3 Europe Anti-thrombin III Testing Market Size by Type (2016-2027)
7.3 Europe Anti-thrombin III Testing Market Size by Application
7.3.1 Europe Anti-thrombin III Testing Market Size by Application (2016-2021)
7.3.2 Europe Anti-thrombin III Testing Market Size by Application (2022-2027)
7.3.3 Europe Anti-thrombin III Testing Market Size by Application (2016-2027)
7.4 Europe Anti-thrombin III Testing Market Size by Country
7.4.1 Europe Anti-thrombin III Testing Market Size by Country (2016-2021)
7.4.2 Europe Anti-thrombin III Testing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Anti-thrombin III Testing Market Size (2016-2027)
8.2 Asia-Pacific Anti-thrombin III Testing Market Size by Type
8.2.1 Asia-Pacific Anti-thrombin III Testing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Anti-thrombin III Testing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Anti-thrombin III Testing Market Size by Type (2016-2027)
8.3 Asia-Pacific Anti-thrombin III Testing Market Size by Application
8.3.1 Asia-Pacific Anti-thrombin III Testing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Anti-thrombin III Testing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Anti-thrombin III Testing Market Size by Application (2016-2027)
8.4 Asia-Pacific Anti-thrombin III Testing Market Size by Region
8.4.1 Asia-Pacific Anti-thrombin III Testing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Anti-thrombin III Testing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Anti-thrombin III Testing Market Size (2016-2027)
9.2 Latin America Anti-thrombin III Testing Market Size by Type
9.2.1 Latin America Anti-thrombin III Testing Market Size by Type (2016-2021)
9.2.2 Latin America Anti-thrombin III Testing Market Size by Type (2022-2027)
9.2.3 Latin America Anti-thrombin III Testing Market Size by Type (2016-2027)
9.3 Latin America Anti-thrombin III Testing Market Size by Application
9.3.1 Latin America Anti-thrombin III Testing Market Size by Application (2016-2021)
9.3.2 Latin America Anti-thrombin III Testing Market Size by Application (2022-2027)
9.3.3 Latin America Anti-thrombin III Testing Market Size by Application (2016-2027)
9.4 Latin America Anti-thrombin III Testing Market Size by Country
9.4.1 Latin America Anti-thrombin III Testing Market Size by Country (2016-2021)
9.4.2 Latin America Anti-thrombin III Testing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Anti-thrombin III Testing Market Size (2016-2027)
10.2 Middle East & Africa Anti-thrombin III Testing Market Size by Type
10.2.1 Middle East & Africa Anti-thrombin III Testing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Anti-thrombin III Testing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Anti-thrombin III Testing Market Size by Type (2016-2027)
10.3 Middle East & Africa Anti-thrombin III Testing Market Size by Application
10.3.1 Middle East & Africa Anti-thrombin III Testing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Anti-thrombin III Testing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Anti-thrombin III Testing Market Size by Application (2016-2027)
10.4 Middle East & Africa Anti-thrombin III Testing Market Size by Country
10.4.1 Middle East & Africa Anti-thrombin III Testing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Anti-thrombin III Testing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Anti-thrombin III Testing Introduction
11.1.4 Abbott Laboratories Revenue in Anti-thrombin III Testing Business (2016-2021)
11.1.5 Abbott Laboratories Recent Development
11.2 Danaher Corp.
11.2.1 Danaher Corp. Company Details
11.2.2 Danaher Corp. Business Overview
11.2.3 Danaher Corp. Anti-thrombin III Testing Introduction
11.2.4 Danaher Corp. Revenue in Anti-thrombin III Testing Business (2016-2021)
11.2.5 Danaher Corp. Recent Development
11.3 F. Hoffmann-La Roche Ltd.
11.3.1 F. Hoffmann-La Roche Ltd. Company Details
11.3.2 F. Hoffmann-La Roche Ltd. Business Overview
11.3.3 F. Hoffmann-La Roche Ltd. Anti-thrombin III Testing Introduction
11.3.4 F. Hoffmann-La Roche Ltd. Revenue in Anti-thrombin III Testing Business (2016-2021)
11.3.5 F. Hoffmann-La Roche Ltd. Recent Development
11.4 Siemens Healthcare GmbH
11.4.1 Siemens Healthcare GmbH Company Details
11.4.2 Siemens Healthcare GmbH Business Overview
11.4.3 Siemens Healthcare GmbH Anti-thrombin III Testing Introduction
11.4.4 Siemens Healthcare GmbH Revenue in Anti-thrombin III Testing Business (2016-2021)
11.4.5 Siemens Healthcare GmbH Recent Development
11.5 Thermo Fisher Scientific Inc.
11.5.1 Thermo Fisher Scientific Inc. Company Details
11.5.2 Thermo Fisher Scientific Inc. Business Overview
11.5.3 Thermo Fisher Scientific Inc. Anti-thrombin III Testing Introduction
11.5.4 Thermo Fisher Scientific Inc. Revenue in Anti-thrombin III Testing Business (2016-2021)
11.5.5 Thermo Fisher Scientific Inc. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Anti-thrombin III Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Diagnosis of antithrombin deficiency
Table 3. Key Players of Activity assays
Table 4. Key Players of Immunological assays
Table 5. Global Anti-thrombin III Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Anti-thrombin III Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Anti-thrombin III Testing Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Anti-thrombin III Testing Market Share by Regions (2016-2021)
Table 9. Global Anti-thrombin III Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Anti-thrombin III Testing Market Share by Regions (2022-2027)
Table 11. Anti-thrombin III Testing Market Trends
Table 12. Anti-thrombin III Testing Market Drivers
Table 13. Anti-thrombin III Testing Market Challenges
Table 14. Anti-thrombin III Testing Market Restraints
Table 15. Global Anti-thrombin III Testing Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Anti-thrombin III Testing Market Share by Players (2016-2021)
Table 17. Global Top Anti-thrombin III Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-thrombin III Testing as of 2020)
Table 18. Ranking of Global Top Anti-thrombin III Testing Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Anti-thrombin III Testing Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Anti-thrombin III Testing Product Solution and Service
Table 22. Date of Enter into Anti-thrombin III Testing Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Anti-thrombin III Testing Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Anti-thrombin III Testing Revenue Market Share by Type (2016-2021)
Table 26. Global Anti-thrombin III Testing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Anti-thrombin III Testing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Anti-thrombin III Testing Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Anti-thrombin III Testing Revenue Market Share by Application (2016-2021)
Table 30. Global Anti-thrombin III Testing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Anti-thrombin III Testing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Anti-thrombin III Testing Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Anti-thrombin III Testing Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Anti-thrombin III Testing Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Anti-thrombin III Testing Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Anti-thrombin III Testing Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Anti-thrombin III Testing Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Anti-thrombin III Testing Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Anti-thrombin III Testing Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Anti-thrombin III Testing Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Anti-thrombin III Testing Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Anti-thrombin III Testing Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Anti-thrombin III Testing Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Anti-thrombin III Testing Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Anti-thrombin III Testing Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Anti-thrombin III Testing Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Anti-thrombin III Testing Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Anti-thrombin III Testing Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Anti-thrombin III Testing Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Anti-thrombin III Testing Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Anti-thrombin III Testing Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Anti-thrombin III Testing Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Anti-thrombin III Testing Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Anti-thrombin III Testing Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Anti-thrombin III Testing Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Anti-thrombin III Testing Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Anti-thrombin III Testing Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Anti-thrombin III Testing Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Anti-thrombin III Testing Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Anti-thrombin III Testing Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Anti-thrombin III Testing Market Size by Country (2022-2027) & (US$ Million)
Table 62. Abbott Laboratories Company Details
Table 63. Abbott Laboratories Business Overview
Table 64. Abbott Laboratories Anti-thrombin III Testing Product
Table 65. Abbott Laboratories Revenue in Anti-thrombin III Testing Business (2016-2021) & (US$ Million)
Table 66. Abbott Laboratories Recent Development
Table 67. Danaher Corp. Company Details
Table 68. Danaher Corp. Business Overview
Table 69. Danaher Corp. Anti-thrombin III Testing Product
Table 70. Danaher Corp. Revenue in Anti-thrombin III Testing Business (2016-2021) & (US$ Million)
Table 71. Danaher Corp. Recent Development
Table 72. F. Hoffmann-La Roche Ltd. Company Details
Table 73. F. Hoffmann-La Roche Ltd. Business Overview
Table 74. F. Hoffmann-La Roche Ltd. Anti-thrombin III Testing Product
Table 75. F. Hoffmann-La Roche Ltd. Revenue in Anti-thrombin III Testing Business (2016-2021) & (US$ Million)
Table 76. F. Hoffmann-La Roche Ltd. Recent Development
Table 77. Siemens Healthcare GmbH Company Details
Table 78. Siemens Healthcare GmbH Business Overview
Table 79. Siemens Healthcare GmbH Anti-thrombin III Testing Product
Table 80. Siemens Healthcare GmbH Revenue in Anti-thrombin III Testing Business (2016-2021) & (US$ Million)
Table 81. Siemens Healthcare GmbH Recent Development
Table 82. Thermo Fisher Scientific Inc. Company Details
Table 83. Thermo Fisher Scientific Inc. Business Overview
Table 84. Thermo Fisher Scientific Inc. Anti-thrombin III Testing Product
Table 85. Thermo Fisher Scientific Inc. Revenue in Anti-thrombin III Testing Business (2016-2021) & (US$ Million)
Table 86. Thermo Fisher Scientific Inc. Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anti-thrombin III Testing Market Share by Type: 2020 VS 2027
Figure 2. Diagnosis of antithrombin deficiency Features
Figure 3. Activity assays Features
Figure 4. Immunological assays Features
Figure 5. Global Anti-thrombin III Testing Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Research institute Case Studies
Figure 8. Clinic Case Studies
Figure 9. Other Case Studies
Figure 10. Anti-thrombin III Testing Report Years Considered
Figure 11. Global Anti-thrombin III Testing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Anti-thrombin III Testing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Anti-thrombin III Testing Market Share by Regions: 2020 VS 2027
Figure 14. Global Anti-thrombin III Testing Market Share by Regions (2022-2027)
Figure 15. Global Anti-thrombin III Testing Market Share by Players in 2020
Figure 16. Global Top Anti-thrombin III Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-thrombin III Testing as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Anti-thrombin III Testing Revenue in 2020
Figure 18. Global Anti-thrombin III Testing Revenue Market Share by Type (2016-2021)
Figure 19. Global Anti-thrombin III Testing Revenue Market Share by Type (2022-2027)
Figure 20. North America Anti-thrombin III Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Anti-thrombin III Testing Market Share by Type (2016-2027)
Figure 22. North America Anti-thrombin III Testing Market Share by Application (2016-2027)
Figure 23. North America Anti-thrombin III Testing Market Share by Country (2016-2027)
Figure 24. United States Anti-thrombin III Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Anti-thrombin III Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Anti-thrombin III Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Anti-thrombin III Testing Market Share by Type (2016-2027)
Figure 28. Europe Anti-thrombin III Testing Market Share by Application (2016-2027)
Figure 29. Europe Anti-thrombin III Testing Market Share by Country (2016-2027)
Figure 30. Germany Anti-thrombin III Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Anti-thrombin III Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Anti-thrombin III Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Anti-thrombin III Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Anti-thrombin III Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Anti-thrombin III Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Anti-thrombin III Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Anti-thrombin III Testing Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Anti-thrombin III Testing Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Anti-thrombin III Testing Market Share by Region (2016-2027)
Figure 40. China Anti-thrombin III Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Anti-thrombin III Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Anti-thrombin III Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Anti-thrombin III Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Anti-thrombin III Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Anti-thrombin III Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Anti-thrombin III Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Anti-thrombin III Testing Market Share by Type (2016-2027)
Figure 48. Latin America Anti-thrombin III Testing Market Share by Application (2016-2027)
Figure 49. Latin America Anti-thrombin III Testing Market Share by Country (2016-2027)
Figure 50. Mexico Anti-thrombin III Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Anti-thrombin III Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Anti-thrombin III Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Anti-thrombin III Testing Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Anti-thrombin III Testing Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Anti-thrombin III Testing Market Share by Country (2016-2027)
Figure 56. Turkey Anti-thrombin III Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Anti-thrombin III Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Anti-thrombin III Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Abbott Laboratories Revenue Growth Rate in Anti-thrombin III Testing Business (2016-2021)
Figure 60. Danaher Corp. Revenue Growth Rate in Anti-thrombin III Testing Business (2016-2021)
Figure 61. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Anti-thrombin III Testing Business (2016-2021)
Figure 62. Siemens Healthcare GmbH Revenue Growth Rate in Anti-thrombin III Testing Business (2016-2021)
Figure 63. Thermo Fisher Scientific Inc. Revenue Growth Rate in Anti-thrombin III Testing Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

---